RxDoctor Payments Data

Justin Bennett

Family Medicine · Alcoa, TNNPI 1396011722

Payments from drug & device makers

$1,798in general payments, 2019–2025

Across 112 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$394
  • Pfizer$329
  • AstraZeneca$265
  • GSK$224
  • Boehringer Ingelheim$219
  • AbbVie$67
  • plus $300 from 8 others

What the payments were for

  • Food & beverage$1,78699%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,798 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$100,090
Medicare patients
300
Services billed
1,236

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban190$175,785
JardianceEmpagliflozin118$151,403
OzempicSemaglutide84$119,080
Trelegy ElliptaFluticasone/Umeclidin/Vilanter49$38,227
FarxigaDapagliflozin Propanediol18$29,975
XareltoRivaroxaban18$26,722
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr22$19,362
MyrbetriqMirabegron29$17,349
TrulicityDulaglutide18$14,882
Breo ElliptaFluticasone/Vilanterol19$13,232
MounjaroTirzepatide15$13,201
LinzessLinaclotide17$11,258
Tresiba Flextouch U-200Insulin Degludec18$10,328
Lantus SolostarInsulin Glargine,hum.Rec.Anlog54$8,807
Albuterol Sulfate HfaAlbuterol Sulfate178$7,836

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$329$182,446201 claims
Boehringer IngelheimJardiance$219$151,403118 claims
Novo NordiskOzempic$65$119,08084 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$224$70,82190 claims
AstraZenecaFarxiga, Breztri Aerosphere$265$37,22030 claims
Lilly USA, LLCTrulicity, Mounjaro$394$28,08333 claims
Astellas Pharma US IncMyrbetriq$52$17,34929 claims
AbbVieLinzess$67$11,25817 claims
Sanofi-aventis U.S. LLCLantus$26$7,14334 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Alcoa

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →